An all-oral, bedaquiline-containing regimen offers a potential salvage option for refractory MAC, reducing reliance on aminoglycoside therapy while requiring continued QT monitoring. "All-Oral ...

Behind every CAR T program is a real cost structure, staffing, drug stocking, and around-the-clock monitoring, that Dr. Graff breaks down as a practical barrier independent of clinical readiness. In ...

This episode, titled 'Expanding Access to Anti-Amyloid Therapy: The Case for Primary Care Prescribing,' featured panelists discussing the following critical questions: How are you enhancing ...

Jorgen Vestbo, MD, discusses new COPERNICOS trial data showing COPD patients who do not meet a specific eosinophil threshold ...

The retrospective study developed colorectal cancer detection with AI (COCA), using 1321 patients with colorectal cancer and ...

Among cause-specific cardiovascular deaths, evolocumab showed directionally favorable effects for acute MI, stroke, and heart ...

In HELIOS-B (n=654), baseline tafamidis use (40%) did not significantly modify vutrisiran’s effect on mortality plus ...

Transplant weight-loss access, a new dermatomyositis drug, mifepristone safety views, and racial gaps in cataract surgery and ...

In "The Next Frontier in Hepatitis B Functional and Virologic Cure," our experts look ahead to the combination strategies and ...

Kalshi, a prediction betting market app, announced new contracts in July 2026 for FDA approvals on various cancer and ...

Keith Bellovich, DO, of Strive Health, discusses how the new CKM guideline unifies cardiology, nephrology, and endocrinology ...

Hospital resources, not clinical preference, often decide which MG rescue therapy a patient receives, Richard Nowak, MD, MS, ...